Clinical Trial Update: Ticagrelor Single Antiplatelet Therapy in Patients With High Risk of Bleeding After DCB for Coronary Small Vessel Disease [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating ticagrelor as single antiplatelet therapy in patients at high risk of bleeding after drug-coated balloon treatment for coronary …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Heart Disease

Drugs mentioned

• TICAGRELOR (ticagrelor)

Snippet

Sponsor: Fu Wai Hospital, Beijing, China | Conditions: Coronary Heart Disease | Phase 4 | Status: UNKNOWN